首页> 美国卫生研究院文献>Scientific Reports >MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy
【2h】

MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy

机译:MicroRNA-140-5p通过靶向HMGN5和自噬来调节骨肉瘤化学耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemotherapy is an important treatment modality for osteosarcoma. However, it often fails because of chemoresistance, especially multidrug resistance. Previously, we found several genes were involved in chemoresistance development. In this report, we used high-throughput microRNA (miRNA) expression analysis to reveal that expression of miR-140-5p was associated with chemosensitivity in osteosarcoma. The exact roles of miR-140-5p in the chemoresistance of osteosarcoma were then investigated, we found that knockdown of miR-140-5p enhanced osteosarcoma cells resistance to multiple chemotherapeutics while overexpression of miR-140-5p sensitized tumors to chemotherapy in vitro. Moreover, in vivo, knockdown of miR-140-5p also increased the osteosarcoma cells resistance to chemotherapy. Luciferase assay and Western blot analysis showed that HMGN5 was the direct target of miR-140-5p which could positively regulated autophagy. Silencing these target genes by siRNA or inhibition of autophagy sensitized osteosarcoma cells to chemotherapy. These findings suggest that a miR-140-5p/HMGN5/autophagy regulatory loop plays a critical role in chemoresistance in osteosarcoma. In conclusion, our data elucidated that miR-140-5p promoted autophagy mediated by HMGN5 and sensitized osteosarcoma cells to chemotherapy. These results suggest a potential application of miR-140-5p in overall survival, chemoresistance prognosis and treatment.
机译:化学疗法是骨肉瘤的重要治疗方式。然而,由于化学抗性,特别是对多药耐药性,它常常失败。以前,我们发现几个基因参与化学抗性的发展。在本报告中,我们使用了高通量的microRNA(miRNA)表达分析来揭示miR-140-5p的表达与骨肉瘤的化学敏感性有关。然后研究了miR-140-5p在骨肉瘤化学耐药性中的确切作用,我们发现敲低miR-140-5p可以增强骨肉瘤细胞对多种化学疗法的抵抗力,而miR-140-5p致敏肿瘤在体外对化疗的过度表达。此外,在体内,敲低miR-140-5p也增加了骨肉瘤细胞对化疗的抵抗力。萤光素酶分析和蛋白质印迹分析表明,HMGN5是miR-140-5p的直接靶标,可正向调节自噬。通过siRNA沉默这些靶基因或抑制自噬致敏性骨肉瘤细胞对化疗的作用。这些发现表明,miR-140-5p / HMGN5 /自噬调节环在骨肉瘤的化学抗性中起关键作用。总之,我们的数据阐明了miR-140-5p促进了HMGN5介导的自噬,并使骨肉瘤细胞对化疗敏感。这些结果表明,miR-140-5p在整体生存,化学耐药性预后和治疗中具有潜在的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号